market access strategy

The EMR-First Shift: Why Market Access Evidence Is Moving Beyond Claims

For years, real-world evidence strategies across pharmaceutical organizations have been built primarily on administrative claims data. Claims datasets have long served as the backbone for understanding utilization trends, reimbursement activity, and treatment adoption...

Beyond Coverage: The 90-Day Clinical Reality Check for Post-Launch Access Performance

Launch strategies are built on carefully modeled assumptions — projected uptake curves, coverage expectations, budget impact forecasts, and prioritized segments designed to drive early performance. But once a product enters the market, projections meet operational...

The Comparator Problem: When “Standard of Care” Isn’t So Standard

In value discussions, few phrases carry more weight than “standard of care.” It’s the benchmark, the reference point, and the foundation for comparative claims. But in today’s market access environment, one uncomfortable reality is becoming harder to ignore: Standard...

When “Good Access” Breaks in the Real World: Why Early Signals Don’t Predict Uptake

For many market access teams, success is measured at a familiar milestone: coverage secured, contracts signed, launch greenlit. On paper, it looks like a win. But in practice, some of the most painful access surprises don’t happen before coverage — they happen after....

When Payers Change the Terms Mid-Negotiation: How Access Teams Stay Ahead

Contracting rarely follows the original script. As negotiations move from early positioning into active deal-making, payer questions evolve. Assumptions get challenged. Thresholds shift. What seemed settled in January suddenly becomes conditional in February. For...

The EMR-First Shift: Why Market Access Evidence Is Moving Beyond Claims

Beyond Coverage: The 90-Day Clinical Reality Check for Post-Launch Access Performance

The Comparator Problem: When “Standard of Care” Isn’t So Standard

When “Good Access” Breaks in the Real World: Why Early Signals Don’t Predict Uptake

When Payers Change the Terms Mid-Negotiation: How Access Teams Stay Ahead

Search by Category:

Recent Posts:

Search by Keyword:

The EMR-First Shift: Why Market Access Evidence Is Moving Beyond Claims

Beyond Coverage: The 90-Day Clinical Reality Check for Post-Launch Access Performance

The Comparator Problem: When “Standard of Care” Isn’t So Standard

When “Good Access” Breaks in the Real World: Why Early Signals Don’t Predict Uptake

When Payers Change the Terms Mid-Negotiation: How Access Teams Stay Ahead

Search by Category:

Recent Posts:

Search by Keyword:

Cookie Consent

Your Privacy Choices

Strictly Necessary (Always Active)

Analytics & Performance

Marketing & Advertising